These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15447987)

  • 1. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
    Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; Nakamori S; Dono K; Umeshita K; Ueno N; Ishii S; Kato K; Monden M
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6029-38. PubMed ID: 15447987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
    Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M
    Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
    Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis.
    Nagano H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Tomimaru Y; Osuga K; Umeshita K; Doki Y; Mori M
    Oncology; 2011; 80(1-2):63-9. PubMed ID: 21659784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
    Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
    Jang JW; Bae SH; Choi JY; Oh HJ; Kim MS; Lee SY; Kim CW; Chang UI; Nam SW; Cha SB; Lee YJ; Chun HJ; Choi BG; Byun JY; Yoon SK
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):9-15. PubMed ID: 16614848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intra arterial infusion chemotherapy combined with interferon-alpha following palliative hepatic resection against advanced hepatoma with portal venous tumor thrombus in the major trunk and multiple nodules--a preliminary study].
    Nagano H; Miyamoto A; Wada H; Noda T; Nakamura M; Ota H; Damdinsuren B; Marubashi S; Takeda Y; Umeshita K; Dono K; Monden M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1848-51. PubMed ID: 17212125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
    Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular-based prediction of early recurrence in hepatocellular carcinoma.
    Kurokawa Y; Matoba R; Takemasa I; Nagano H; Dono K; Nakamori S; Umeshita K; Sakon M; Ueno N; Oba S; Ishii S; Kato K; Monden M
    J Hepatol; 2004 Aug; 41(2):284-91. PubMed ID: 15288478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.
    Obi S; Yoshida H; Toune R; Unuma T; Kanda M; Sato S; Tateishi R; Teratani T; Shiina S; Omata M
    Cancer; 2006 May; 106(9):1990-7. PubMed ID: 16565970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapy.
    Moriyama M; Hoshida Y; Kato N; Otsuka M; Yoshida H; Kawabe T; Omata M
    Int J Oncol; 2004 Nov; 25(5):1279-87. PubMed ID: 15492816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A report of two cases--two patients of the extremely advanced hepatocellular carcinoma have responded completely for a long time after a combination therapy consisting of arterial chemotherapy and injection of interferon-alpha].
    Iijima S; Kikkawa N; Kurokawa E; Yamamoto H; Kato T; Tsujie M; Ohshima S; Hayashi T; Naoi Y; Hatanaka T; Danno M; Sakon M; Nagano H; Dono K; Nakamori S; Umeshita K; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1669-72. PubMed ID: 14619490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Marubashi S; Miyamoto A; Nagano H; Dono K; Umeshita K; Nakamori S; Sakon M; Aozasa K; Monden M
    J Gastroenterol; 2004 Aug; 39(8):793-7. PubMed ID: 15338375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Kojima Y; Iwasa S; Hagihara A
    Jpn J Clin Oncol; 2008 Oct; 38(10):675-82. PubMed ID: 18716041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis.
    Nakamura M; Nagano H; Marubashi S; Miyamoto A; Takeda Y; Kobayashi S; Wada H; Noda T; Dono K; Umeshita K; Monden M
    Cancer; 2008 Apr; 112(8):1765-71. PubMed ID: 18327806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.